Peptides and Regulation
A deep dive into the influence of private industry on regulatory bodies reveals how the majority of funding shapes the discussion around peptides. With over 7000 peptides available, the conversation highlights the distinction between patented and unpatented peptides, emphasizing that those still on the market are often backed by big pharma. The complexities of compliance and the relationship between the DOJ and pharmacy benefit managers further illustrate the challenges within the pharmaceutical landscape.In this clip
From this podcast
The Joe Rogan Experience
Joe Rogan Experience #2079 - Brigham Buhler
Related Questions
Why are peptides restricted by the FDA in the episode 442: Your Guide to Health Freedom in a System Built for Profit | Brigham Buhler and the clip Peptides and Regulation?
Why are peptides restricted by the FDA in the episode 442: Your Guide to Health Freedom in a System Built for Profit | Brigham Bueller and the clip Peptides and Regulation?
Why are peptides restricted by the FDA in the episode 442: Your Guide to Health Freedom in a System Built for Profit | Brigham Bueller and the clip Peptides and Regulation?